Nanomedicine News

RSS

Lipid-Based Nanocapsule Drug Delivery Method Smuggles Drug into Cancer Cell before Release

Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before triggering its release. The method can be likened to keeping a cancer-killing bomb and its detonator separate until they are inside a cancer cell, where they then combine to destroy the cell.

From North Carolina State University 12 May 2014

Researchers Target RNAi to Endothelial Cells Using Nanoparticles

RNA interference (RNAi), a technique that can turn off specific genes inside living cells, holds great potential for treating many diseases caused by malfunctioning genes. However, it has been difficult for scientists to find safe and effective ways to deliver gene-blocking RNA to the correct targets.

From Massachusetts Institute of Technology 12 May 2014

BIND Provides Update on BIND-014 Clinical Development Plan and Reports 1Q 2014 Financial Results

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the first quarter ended March 31, 2014.

9 May 2014

Two Drugs Packaged in Liposome Nanoparticles Dramatically Shrink Tumors

MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.

From Massachusetts Institute of Technology 9 May 2014

NanoViricides Synthesizes Drug Candidates for Testing Infection with MERS Corona Virus

NanoViricides, Inc. (the "Company") reported today that it has designed and synthesized novel nanoviricides® drug candidates in quantities sufficient for testing in animals infected with the MERS Corona Virus.

From NanoViricides, Inc 7 May 2014

Azaya Partners with University of Chicago to Study Taxotere Chemotherapy Agent

Azaya Therapeutics, Inc., a clinical-stage oncology company developing safer and more effective cancer treatments through its nanotechnology platform, announced a collaboration with the University of Chicago, in Chicago, Illinois.

7 May 2014

Capricor Executes Exclusive License Agreement for Exosome Intellectual Property with Cedars-Sinai Medical Center

Capricor Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced the execution of an Exclusive License Agreement with Cedars-Sinai Medical Center for intellectual property (IP) related to the development of exosomes.

7 May 2014

Two Keys Open Tunable Virus That Works Like a Safe Deposit Box

Rice University scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapeutic cargo.

7 May 2014

Cystinosis Research Foundation Raises $2.3 Million for New Research Using Nanotechnology

The Cystinosis Research Foundation raised a record $2.3 million at its annual fundraiser for new research to improve cystinosis treatments and continue progress to cure the rare metabolic disease. Cystinosis destroys the body’s organs and afflicts about 2,000 people, mostly children, worldwide.

6 May 2014

pSivida Presents Poster on ‘Sustained Release of Bevacizumab from BioSilicon’ at 14th ARVO

pSivida Corp., a leader in the development of sustained release products for treating eye diseases, today announced that the Company presented the first peer-reviewed preclinical data demonstrating the use of pSivida’s Tethadur™ technology to provide sustained release of Avastin at the 14th Annual Meeting of ARVO (Association for Research in Vision and Ophthalmology).

From EyePoint Pharmaceuticals, Inc. 6 May 2014

Nanomedicine News

Lipid-Based Nanocapsule Drug Delivery Method Smuggles Drug into Cancer Cell before Release

Researchers Target RNAi to Endothelial Cells Using Nanoparticles

BIND Provides Update on BIND-014 Clinical Development Plan and Reports 1Q 2014 Financial Results

Two Drugs Packaged in Liposome Nanoparticles Dramatically Shrink Tumors

NanoViricides Synthesizes Drug Candidates for Testing Infection with MERS Corona Virus

Azaya Partners with University of Chicago to Study Taxotere Chemotherapy Agent

Capricor Executes Exclusive License Agreement for Exosome Intellectual Property with Cedars-Sinai Medical Center

Two Keys Open Tunable Virus That Works Like a Safe Deposit Box

Cystinosis Research Foundation Raises $2.3 Million for New Research Using Nanotechnology

pSivida Presents Poster on ‘Sustained Release of Bevacizumab from BioSilicon’ at 14th ARVO

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials